Medicine Cabinet Makeover: Revolutionizing the Future Treatment of Upper Respiratory Viruses
January 8, 2024
A scientific breakthrough that stops viruses from sticking
Cold and flu season is upon us. Treating and alleviating the common cold can be challenging — but Enzymatica has discovered something that might change that!
Enzymatica AB is a Swedish consumer biotech company that has made a genuine technological breakthrough that could change the future of self-care. It gives hope that in the future, people will have a totally new ability to protect themselves from airborne viruses that cause upper respiratory tract infections like cold and flu and potentially shorten the symptoms of the infection.
It works by forming a barrier that traps the viruses so viruses can’t attach to and infect human cells. The barrier deactivates the viruses and stops them from sticking. It is applied as a convenient, fast-acting mouth spray that creates an enzyme barrier. This shield protects people directly, even at the first signs of a cold or flu, defending the body from continued viral attachment.
PROMOTED
You may recognize Dr. Tracy Dixon Salazar, Executive Director of LGS Foundation from her feature on the TODAY show, but her story was first shared on our television and social platform, Behind the Mystery. Within these episodes, Tracy shares her daughter Savannah’s Lennox-Gastaut Syndrome journey, and how she advocates for those living with LGS. She […]
PROMOTED
Betterment is the automated investing and savings app that makes it easy to be invested.
PROMOTED
Seven Seas Grandeur™ exemplifies Regent Seven Seas Cruises' Heritage of Perfection with unrivaled space, unparalleled service, epicurean indulgence, and transformative experiences for guests as soon as they step on board.
